71 related articles for article (PubMed ID: 10914718)
1. Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8.
Kitadai Y; Haruma K; Mukaida N; Ohmoto Y; Matsutani N; Yasui W; Yamamoto S; Sumii K; Kajiyama G; Fidler IJ; Tahara E
Clin Cancer Res; 2000 Jul; 6(7):2735-40. PubMed ID: 10914718
[TBL] [Abstract][Full Text] [Related]
2. IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma.
Sharma I; Singh A; Siraj F; Saxena S
J Biomed Sci; 2018 Aug; 25(1):62. PubMed ID: 30086759
[TBL] [Abstract][Full Text] [Related]
3. The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma.
Stronach EA; Cunnea P; Turner C; Guney T; Aiyappa R; Jeyapalan S; de Sousa CH; Browne A; Magdy N; Studd JB; Sriraksa R; Gabra H; El-Bahrawy M
Oncotarget; 2015 Oct; 6(31):31593-603. PubMed ID: 26267317
[TBL] [Abstract][Full Text] [Related]
4. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells.
Miyamoto M; Shimizu Y; Okada K; Kashii Y; Higuchi K; Watanabe A
Cancer Immunol Immunother; 1998 Sep; 47(1):47-57. PubMed ID: 9755878
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes of interleukin-8 network along the colorectal adenoma-carcinoma sequence.
Cui G; Yuan A; Goll R; Vonen B; Florholmen J
Cancer Immunol Immunother; 2009 Nov; 58(11):1897-905. PubMed ID: 19350238
[TBL] [Abstract][Full Text] [Related]
6. Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation.
Shen CJ; Chan RH; Lin BW; Li NC; Huang YH; Chang WC; Chen BK
Theranostics; 2023; 13(13):4650-4666. PubMed ID: 37649607
[No Abstract] [Full Text] [Related]
7. CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors.
Molczyk C; Singh RK
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831112
[TBL] [Abstract][Full Text] [Related]
8. Application progress of liquid biopsy in gastric cancer.
Ma X; Ou K; Liu X; Yang L
Front Oncol; 2022; 12():969866. PubMed ID: 36185234
[TBL] [Abstract][Full Text] [Related]
9. PADI4 promotes epithelial-mesenchymal transition(EMT) in gastric cancer via the upregulation of interleukin 8.
Chang XT; Wu H; Li HL; Li HL; Zheng YB
BMC Gastroenterol; 2022 Jan; 22(1):25. PubMed ID: 35045833
[TBL] [Abstract][Full Text] [Related]
10. NF-κB in Gastric Cancer Development and Therapy.
Chaithongyot S; Jantaree P; Sokolova O; Naumann M
Biomedicines; 2021 Jul; 9(8):. PubMed ID: 34440074
[TBL] [Abstract][Full Text] [Related]
11. Potential mechanisms of tumor progression associated with postoperative infectious complications.
Tsujimoto H; Kobayashi M; Sugasawa H; Ono S; Kishi Y; Ueno H
Cancer Metastasis Rev; 2021 Mar; 40(1):285-296. PubMed ID: 33389285
[TBL] [Abstract][Full Text] [Related]
12. Combination of Serum Amyloid A and C-Reactive Protein Exhibit Synergistic Effect in Angiogenesis by Inducing Inflammation and Vascular Network.
Liu D; Chen Y; Wang Y; Lei M; Chen L; Liang R; Cheng Z; Shi W; Wang H; Lin L; Wang L; Lin F; Lin H; Liu W
Front Oncol; 2020; 10():576207. PubMed ID: 33364190
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Early Diagnosis of Gastric Cancer Discovered after
Ito M; Tanaka S; Chayama K
Gut Liver; 2021 May; 15(3):338-345. PubMed ID: 32321202
[TBL] [Abstract][Full Text] [Related]
14. Serum Levels of Interleukin-8 and Soluble Interleukin-6 Receptor in Patients with Stage-I Multiple Myeloma: A Case-Control Study.
Kohsari M; Khadem-Ansari MH; Rasmi Y; Sayyadi H
Asian Pac J Cancer Prev; 2020 Jan; 21(1):127-132. PubMed ID: 31983174
[TBL] [Abstract][Full Text] [Related]
15. Tumor angiogenesis: causes, consequences, challenges and opportunities.
Lugano R; Ramachandran M; Dimberg A
Cell Mol Life Sci; 2020 May; 77(9):1745-1770. PubMed ID: 31690961
[TBL] [Abstract][Full Text] [Related]
16. Real Microgravity Influences the Cytoskeleton and Focal Adhesions in Human Breast Cancer Cells.
Nassef MZ; Kopp S; Wehland M; Melnik D; Sahana J; Krüger M; Corydon TJ; Oltmann H; Schmitz B; Schütte A; Bauer TJ; Infanger M; Grimm D
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261642
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Guan XW; Zhao F; Wang JY; Wang HY; Ge SH; Wang X; Zhang L; Liu R; Ba Y; Li HL; Deng T; Zhou LK; Bai M; Ning T; Zhang HY; Huang DZ
Am J Cancer Res; 2017; 7(9):1913-1925. PubMed ID: 28979813
[TBL] [Abstract][Full Text] [Related]
18. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
[TBL] [Abstract][Full Text] [Related]
19. Suppression of IL-8-Src signalling axis by 17β-estradiol inhibits human mesenchymal stem cells-mediated gastric cancer invasion.
Liu CJ; Kuo FC; Wang CL; Kuo CH; Wang SS; Chen CY; Huang YB; Cheng KH; Yokoyama KK; Chen CL; Lu CY; Wu DC
J Cell Mol Med; 2016 May; 20(5):962-72. PubMed ID: 26945908
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-8: A potent promoter of angiogenesis in gastric cancer.
Shi J; Wei PK
Oncol Lett; 2016 Feb; 11(2):1043-1050. PubMed ID: 26893688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
